Related Articles
Classification of tumor microenvironment immune types based on immune response-associated gene expression
Identification of tumor microenvironment‑associated immunological genes as potent prognostic markers in the cancer genome analysis project HOPE
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1<sup>low/negative</sup> non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapy
The prognostic significance of PD-L1 in bladder cancer
Status and prognostic value of immunological biomarkers of breast cancer